New York Life Investment Management LLC Takes $850,000 Position in Houlihan Lokey, Inc. $HLI

New York Life Investment Management LLC bought a new stake in Houlihan Lokey, Inc. (NYSE:HLIFree Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 4,881 shares of the financial services provider’s stock, valued at approximately $850,000.

Several other institutional investors and hedge funds also recently made changes to their positions in HLI. Royal Bank of Canada raised its holdings in shares of Houlihan Lokey by 14.4% in the first quarter. Royal Bank of Canada now owns 49,584 shares of the financial services provider’s stock valued at $8,008,000 after purchasing an additional 6,253 shares during the last quarter. AQR Capital Management LLC raised its holdings in shares of Houlihan Lokey by 50.0% in the first quarter. AQR Capital Management LLC now owns 29,654 shares of the financial services provider’s stock valued at $4,598,000 after purchasing an additional 9,891 shares during the last quarter. Millennium Management LLC purchased a new stake in shares of Houlihan Lokey in the first quarter valued at about $18,964,000. Goldman Sachs Group Inc. raised its holdings in shares of Houlihan Lokey by 5.7% in the first quarter. Goldman Sachs Group Inc. now owns 415,743 shares of the financial services provider’s stock valued at $67,143,000 after purchasing an additional 22,553 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership purchased a new stake in shares of Houlihan Lokey in the second quarter valued at about $1,033,000. Hedge funds and other institutional investors own 78.07% of the company’s stock.

Houlihan Lokey Stock Performance

NYSE HLI opened at $147.42 on Wednesday. Houlihan Lokey, Inc. has a 52-week low of $134.41 and a 52-week high of $211.78. The company has a 50-day simple moving average of $148.73 and a 200 day simple moving average of $166.20. The company has a market capitalization of $10.29 billion, a PE ratio of 23.70, a price-to-earnings-growth ratio of 1.18 and a beta of 0.99.

Houlihan Lokey (NYSE:HLIGet Free Report) last issued its earnings results on Wednesday, May 6th. The financial services provider reported $1.63 earnings per share for the quarter, missing analysts’ consensus estimates of $1.79 by ($0.16). The business had revenue of $635.64 million for the quarter, compared to the consensus estimate of $679.22 million. Houlihan Lokey had a return on equity of 22.88% and a net margin of 16.26%.Houlihan Lokey’s revenue for the quarter was down 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.96 EPS. As a group, analysts forecast that Houlihan Lokey, Inc. will post 8.54 EPS for the current fiscal year.

Houlihan Lokey Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a dividend of $0.70 per share. This is a boost from Houlihan Lokey’s previous quarterly dividend of $0.60. This represents a $2.80 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Monday, June 1st. Houlihan Lokey’s dividend payout ratio (DPR) is 38.59%.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Zacks Research downgraded shares of Houlihan Lokey from a “hold” rating to a “strong sell” rating in a report on Wednesday, May 13th. Weiss Ratings downgraded shares of Houlihan Lokey from a “hold (c+)” rating to a “hold (c)” rating in a report on Tuesday, April 21st. Keefe, Bruyette & Woods decreased their price objective on shares of Houlihan Lokey from $177.00 to $172.00 and set an “outperform” rating for the company in a report on Thursday, May 7th. The Goldman Sachs Group decreased their price objective on shares of Houlihan Lokey from $210.00 to $184.00 and set a “buy” rating for the company in a report on Wednesday, April 1st. Finally, UBS Group set a $160.00 price objective on shares of Houlihan Lokey in a report on Thursday, May 7th. Five equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Houlihan Lokey currently has an average rating of “Hold” and a consensus target price of $191.29.

Read Our Latest Analysis on Houlihan Lokey

Insiders Place Their Bets

In other Houlihan Lokey news, General Counsel Christopher M. Crain sold 500 shares of the stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $143.40, for a total transaction of $71,700.00. Following the completion of the transaction, the general counsel owned 500 shares in the company, valued at $71,700. This trade represents a 50.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 22.83% of the stock is owned by corporate insiders.

Houlihan Lokey Company Profile

(Free Report)

Houlihan Lokey, Inc is a global investment bank and financial services firm founded in 1972 and headquartered in Los Angeles, California. The company specializes in advisory services across a broad range of transaction types and financial matters. Since its founding, Houlihan Lokey has grown to serve corporations, financial sponsors, and government entities worldwide, providing expertise in complex and high-stakes engagements.

The firm’s core service offerings include mergers and acquisitions advisory, capital markets advisory, financial restructuring and distressed M&A, and valuation and fairness opinions.

See Also

Want to see what other hedge funds are holding HLI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Houlihan Lokey, Inc. (NYSE:HLIFree Report).

Institutional Ownership by Quarter for Houlihan Lokey (NYSE:HLI)

Receive News & Ratings for Houlihan Lokey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Houlihan Lokey and related companies with MarketBeat.com's FREE daily email newsletter.